Brief: Medigene Publishes Topline Interim Data From Ongoing Phase I/II Clinical Trial

Medigene AG

19/12/2018 20:45

Dec 19 (Reuters) - Medigene AG  MDG1k.DE :
    * MEDIGENE PUBLISHES TOPLINE INTERIM DATA FROM ONGOING PHASE
I/II
CLINICAL TRIAL WITH DC VACCINES IN AML PATIENTS
    * MEDIGENE SAYS VACCINATIONS WERE WELL TOLERATED WITH NO
SERIOUS
ADVERSE EVENTS (SAES) RELATED TO TREATMENT IN ONGOING TRIAL

Source text for Eikon:  urn:newsml:reuters.com:*:nPexlJWtga
Further company coverage:  MDG1k.DE 

 ((Reuters.Briefs@thomsonreuters.com;))